- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00308659
Study to Evaluate Two Diagnostic Strategies for the Treatment of Severe Community Acquired Pneumonia (SCAP)
Diagnostic Strategy Evaluation Study of Two Diagnostic Strategies for the Treatment of SCAP : Noninvasive Strategy and Semiinvasive Strategy Including FOB Distal Samplings
Main hypothesis: microbiological diagnossis off severe community acquired pneumonia can be performed by non invasive or semi invasive microbiological tools, semi invasive tools including protected distal bronchial samplings by the mean of Fiber optic bronchoscopy (FOB). A microbiological diagnosis could improve antibiotic therapy efficacy and improve patient's outcome.
These Two strategies have never been prospectivally evauated.
- Aim of the study: To evaluate 2 diagnostic strategies: non invasive or semi invasive including protected distal bronchial samplings by the mean of Fiber optic bronchoscopy (FOB)for the care of patients admitted in intensive care for severe community acquired pneumonia and receiving an empirical antibiotic therapy as recommanded by 2001 American thoracic guidelines
- Type of study randomized multicentric controlled open study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Type of study randomized multicentric controlled open study
Number of patients: 200 patients (100 patients in each group)admitted in ICU for SCAP
- Number of center : 5
- Clinical strategies under evaluation :
- Group A: semi-invasive strategy: FOB within 24 hours after ICU admission
- Group B: non-invasive strategy: no FOB within 24 hours after ICU admission
- Evaluation criteria:
Main criteria: Changes in initial empirical antibiotic treatment according to microbiological results obtained in each group.
others
- FOB related complications
- Microbiological results
- Type of antibiotic treatment modifications
- ICU outcome and outcome at day 28
- Duration of antibiotic therapy and nimber of days without antibiotics at day 28 after inclusion
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: HERER BERTRAND, MD
- Phone Number: +33141878801
- Email: formation-aducation@cardif.asso.fr
Study Locations
-
-
-
Paris, France, 75004
- Recruiting
- Hotel Dieu
-
Contact:
- Rabbat antoine, MD
- Phone Number: +33142348637
- Email: antoine.rabbat@htd.aphp.fr
-
Principal Investigator:
- Rabbat antoine, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
New radiological infiltrate SCAP clinical diagnosis admitted in ICU Admitted in hospital for less than 24 hours Aged 18 or older Signed informed consent
Exclusion Criteria:
Pregnancy Muribond patients Previuos hospitalisation within One month Neutropenia None HIV status
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Collaborators and Investigators
Investigators
- Principal Investigator: RABBAT Antoine, MD, APHP
Study record dates
Study Major Dates
Study Start
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCAP FOB
- CNMR grant, cardiff
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Community Aquired Pneumonia
-
Aga Khan UniversityBill and Melinda Gates FoundationCompletedChildhood Diarrhea | Childhood Pneumonia | Community Mobilisation | Sanitation and Hygiene | Community IncentivesPakistan
-
Future University in EgyptRecruitingCommunity-acquired PneumoniaEgypt
-
Nordsjaellands HospitalRecruitingCommunity-acquired PneumoniaDenmark
-
Thomas BenfieldRecruitingCommunity-acquired PneumoniaDenmark
-
Hannover Medical SchoolRecruitingCommunity-acquired PneumoniaGermany
-
University of Roma La SapienzaAzienda Policlinico Umberto IRecruitingCommunity-acquired PneumoniaItaly
-
Julia BielickiUniversity Hospital, Basel, Switzerland; Swiss National Fund for Scientific...CompletedCommunity-acquired PneumoniaSwitzerland, Germany
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Asian Foundation for Tropical Medicine Inc.Pfizer; Southern Philippines Medical Center; Philippine Children's Medical Center...Active, not recruitingCommunity-acquired PneumoniaPhilippines
-
TaiGen Biotechnology Co., Ltd.Completed